Results 251 to 260 of about 30,994 (308)
Some of the next articles are maybe not open access.

GIP(3-30)NH2 – a tool for the study of GIP physiology

Current Opinion in Pharmacology, 2020
Glucose-dependent insulinotropic polypeptide (GIP) is a gut hormone impacting glucose, lipid and bone metabolism through the GIP receptor (GIPR). The GIP system has key species differences complicating the translation of findings from rodent to human physiology.
Mads Bank Lynggaard   +3 more
openaire   +3 more sources

Effect of Sleeve Gastrectomy on Ghrelin, GLP-1, PYY, and GIP Gut Hormones: A Systematic Review and Meta-analysis.

Annals of Surgery, 2020
OBJECTIVE To perform a structured systematic review and meta-analysis to evaluate changes in ghrelin, glucagon-like peptide-1 (GLP-1), peptide YY (PYY), and gastric inhibitory peptide (GIP) gut hormone levels in patients after sleeve gastrectomy ...
T. McCarty   +2 more
semanticscholar   +1 more source

The gastrocolic response: Is it gip?

Journal of Surgical Research, 1980
Abstract Previous experiments demonstrated that feeding is followed by increased electrical spike discharges and contractions of colon smooth muscle. This gastrocolic response has a definite lag period before onset, and is not due to distention of the colon by food. In these experiments, the possible association between altered serum concentration of
L F, Sillin   +4 more
openaire   +2 more sources

GIP

Proceedings of the first workshop on Wireless mobile internet, 2001
The GPRS and UMTS specifications define the procedures supporting the mobility and the data sessions of a mobile user moving within the area of the corresponding PLMNs. For the case, though, of mobile users working in group, using a PLMN infrastructure, the aforementioned networks foresee no special treatment.
Constantinos F. Grecas   +2 more
openaire   +1 more source

Compounded GLP 1 and Dual GIP/GLP 1 Receptor Agonists: A Statement from the American Diabetes Association.

Diabetes Care
The use of glucagon-like peptide 1 receptor agonist (GLP-1 RA) and dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 RA (GIP/GLP-1 RA) classes has increased substantially over the past several years for treating type 2 diabetes and ...
J. Neumiller   +6 more
semanticscholar   +1 more source

GIP and Bariatric Surgery

Obesity Surgery, 2010
Bariatric surgery is the most effective modality of achieving weight loss as well as the most effective treatment for type 2 diabetes mellitus (T2DM). Glucose-dependent insulinotropic polypeptide (GIP) is an incretin and is implicated in the pathogenesis of obesity and T2DM. Its role in weight loss and resolution of T2DM after bariatric surgery is very
Raghavendra S, Rao, Subhash, Kini
openaire   +2 more sources

Regulatory development of geriatric medicines: To GIP or not to GIP?

Ageing Research Reviews, 2016
Geriatric patients represent the main users of medicines, but are historically often minimally included in clinical trials, resulting in a gap in the knowledge of the benefit/risk balance of medicines in this heterogeneous population. As the worldwide population is aging, the need for safe and effective medicines for older patients is proportionally ...
Bart, De Spiegeleer   +6 more
openaire   +2 more sources

Physiology of GIP - A Lesson from GIP Receptor Knockout Mice

Hormone and Metabolic Research, 2004
A much greater insulin response is observed after oral glucose load than after intravenous injection of glucose. The hormonal factor(s) implicated as transmitters of signals from the gut to pancreatic beta-cells was referred to incretin; gastric inhibitory polypeptide or glucose-dependent insulinotropic polypeptide (GIP) is identified as one of the ...
Y, Yamada, Y, Seino
openaire   +2 more sources

Physiology and Pathophysiology of GIP

1978
Two major physiological roles for GIP have been established. An enterogastrone-like action in dog, in which it has been shown that physiological doses of the hormone will inhibit gastric acid secretion stimulated by histamine, gastrin or insulin hypoglycaemia (1) and an insulinotropic action of the hormone in both dog and man (2,3).
J C, Brown   +4 more
openaire   +2 more sources

Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.

Neuropharmacology, 2020
The sister incretins glucagon-like peptide-1 (GLP-1) and glucagon dependent insulinotropic polypeptide (GIP) are growth factors responsible for re-sensitizing insulin signalling.
Geisa Nogueira Salles   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy